Product ID |
CAS Number |
Product Name |
Quantity |
AS-2121 |
75583-37-6 |
2-Chloro-4-bromopyridine |
|
AS-2123 |
89976-12-5 |
2-METHYL-5-NITROBENZOTRIFLUORIDE |
|
AS-3079 |
38632-00-7 |
(6b)-6-Bromoandrost-4-ene-3,17-dione |
|
AS-3086 |
611-33-6 |
8-Chloroquinoline |
|
AS-3184 |
694-53-1 |
PHENYLSILANE |
|
AS-3194 |
451-40-1 |
2-Phenylacetophenone |
|
AS-3610 |
141505-33-1 |
Levosimendan |
|
AS-4114 |
156-28-5 |
2-Phenylethylamine hydrochloride |
|
AS-4123 |
6969-71-7 |
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one |
|
AS-4126 |
2491-20-5 |
L-Alanine methyl ester hydrochloride |
|
AS-4128 |
68957-94-8 |
2,4,6-TRIPROPYL-1,3,5,2,4,6-TRIOXATRIPHOSPHORINANE-2,4,6-TRIOXIDE |
|
AS-4129 |
2438-72-4 |
Bufexamac |
|
AS-4138 |
99-94-5 |
p-Toluic acid |
|
AS-4143 |
55-81-2 |
4-Methoxyphenethylamine |
|
AS-4320 |
177952-38-4 |
2,4-BIS(TRIFLUOROMETHYL)BENZONITRILE |
|
AS-4409 |
317319-10-1 |
Acetic acid, 2-(4-hydroxy-2-methylphenoxy)-, methyl ester |
|
AS-4411 |
99548-55-7 |
BENZOIC ACID,4-BROMO-2-METHYL-,METHYL ESTER |
|
AS-4414 |
3168-59-0 |
5-METHOXY-2-METHYL-BENZOIC ACID |
|
AS-4417 |
108166-03-6 |
2-Methyl-6-quinolinecarbaldehyde |
|
AS-4607 |
103698-10-8 |
Methyl 3-nitroisonicotinate |
|
AS-4953 |
188815-32-9 |
3-BROMO-5-IODOBENZOIC ACID |
|
AS-4966 |
16801-63-1 |
4-N-Cbz-cyclohexanone |
|
AS-5245 |
139-66-2 |
Diphenyl sulfide |
|
AS-5250 |
2815-34-1 |
trans-2,5-Dimethylpiperazine |
|
AS-5251 |
6833-47-2 |
trans-4-Ethylcyclohexanecarboxylic acid |
|
AS-5257 |
11/2/6556 |
Inositol nicotinate |
|
AS-6040 |
607-81-8 |
Diethyl benzylmalonate |
|
AS-6848 |
2906-60-7 |
3-CARBOXYPROPYL DISULFIDE |
|
AS-7688 |
1119-85-3 |
1,4-DICYANO-2-BUTENE |
|
AS-8274 |
161321-36-4 |
FMOC-CHG-OH |
|
AS-8276 |
700874-72-2 |
LY 2157299 |
|
AS-8279 |
3615-41-6 |
alpha-L-Rhamnose |
|
AS-8725 |
1190311-94-4 |
6-Bromo-3-nitro-4-azaindole |
|
JR6-L3350 |
767330-47-2 |
[1,1'-Binaphthalene]-2,2'-diol, 3-phenyl-, (1S)- |
|
JR8-N0358 |
541-91-3 |
Muscone |
|
JR8-N0627 |
524-12-9 |
Wedelolactone |
|
JR8-N0633 |
14937-32-7 |
1,2,3,4,6-O-pentagalloylglucose |
|
|
|
|
|
|
|
|
|
|
|
|
|